RS

Raihan Saeeda

Active Director Director DIN 00624256
DIN 00624256 First appointment Apr 1997 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 1997
Shareholding value •••• Premium profile

About Raihan Saeeda

Data last updated:

Raihan Saeeda is a Director at Lorda Pharmaceuticals Private Limited (since 1997). The company operates in Pharma. Lorda Pharmaceuticals Private Limited reported revenue of ₹94,569 (FY 2016).

DIN 00624256
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 1997
Oldest Company Age 34 yrs
Largest company Lorda Pharmaceuticals Private Limited · ₹94,569 (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 19971992₹94,569 (FY 2016)Active

Board colleagues of Raihan Saeeda

Directorship timeline

Open interactive timeline →
Lorda Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Raihan Saeeda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raihan Saeeda

Raihan Saeeda currently holds 1 directorship: Lorda Pharmaceuticals Private Limited (Director, since 01 Apr 1997, revenue ₹94,569 (FY 2016)).

Raihan Saeeda was first appointed on 01 Apr 1997 as Director at Lorda Pharmaceuticals Private Limited.

The current boards of Raihan Saeeda's companies include Anwer Saeeda (Lorda Pharmaceuticals Private Limited), Barirah Ahmad (Lorda Pharmaceuticals Private Limited), Makeen Ahmad (Lorda Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available